Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Enhanced immune sensitivity to stress following chronic morphine exposure.

Ballard KA, Pellegrino TC, Alonzo NC, Nugent AL, Bayer BM.

J Neuroimmune Pharmacol. 2006 Mar;1(1):106-15.

PMID:
18040796
2.

Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine.

Avila AH, Alonzo NC, Bayer BM.

J Neuroimmunol. 2004 Feb;147(1-2):109-13.

PMID:
14741439
3.

Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.

Alonzo NC, Bayer BM.

J Pharmacol Exp Ther. 2003 Nov;307(2):793-800. Epub 2003 Sep 9.

PMID:
12966157
4.

Opioids, immunology, and host defenses of intravenous drug abusers.

Alonzo NC, Bayer BM.

Infect Dis Clin North Am. 2002 Sep;16(3):553-69. Review.

PMID:
12371115
5.

Morphine reduces mortality in mice following ocular infection with HSV-1.

Alonzo NC, Carr DJ.

Immunopharmacology. 1999 Apr;41(3):187-97.

PMID:
10428647
6.

Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels.

Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM.

J Neuropathol Exp Neurol. 1998 Apr;57(4):353-9.

PMID:
9600229
7.

Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.

Rebeck GW, Alonzo NC, Berezovska O, Harr SD, Knowles RB, Growdon JH, Hyman BT, Mendez AJ.

Exp Neurol. 1998 Jan;149(1):175-82.

PMID:
9454626

Supplemental Content

Loading ...
Support Center